Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

NEHI

New Jersey Healthcare Leaders Hold Summit on Key Challenges

Healthcare Today 5Princeton, NJ, April 22, 2016 ― Members of New Jersey’s various healthcare communities — hospitals, health plans, physicians and life sciences — gathered yesterday at the New Jersey Hospital Association for a daylong event to discuss the key challenges facing the healthcare delivery system.

The New Jersey Healthcare Stakeholder Summit focused on the importance of collaboration across sectors, which all share the goal of providing high-quality, cost-effective healthcare services that are accessible to all.

The event was a joint effort of the HealthCare Institute of New Jersey (HINJ), the Medical Society of New Jersey (MSNJ), the New Jersey Association of Health Plans (NJAHP) and the New Jersey Hospital Association (NJHA). Continue reading

Tomorrow! HINJ and NEHI to Host ‘Innovation in an Era of Payment Reform’ Forum on April 1

New Brunswick, NJ, March 31, 2014 — The HealthCare Institute of New Jersey (HINJ) and NEHI (The Network for Excellence in Health Innovation) will host “Innovation in an Era of Payment Reform: How Will New Jersey’s Life Sciences Companies Respond?” on Tuesday, April 1 from 8:30 to 11:30 a.m. at the Crowne Plaza Monroe South Brunswick in Monroe Township, NJ.

Health care payment reform is already transforming the way health care providers deliver care throughout the United States.  Payment reform will not only influence the quality and cost of health care, it will also impact innovation in New Jersey’s historically dynamic life sciences sector.  Continue reading